Quantum Financial Partners
AMRX icon

Quantum Financial Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Quantum Financial Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$248K Buy
12,300
+2,000
+19% +$36K 0.13% 133
2026
Q2 		$178K Buy
+10,300
New +$141K 0.09% 150

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Quantum Financial Partners's AMRX Position: Q3 2026 in Review

Quantum Financial Partners increased its Amneal Pharmaceuticals (AMRX) stake by 19% in Q3 2026, buying an estimated $36K and bringing the position to 12,300 shares worth $248K. The position accounts for 0.13% of the portfolio, ranked #133.

Quantum Financial Partners first reported a position in AMRX in Q2 2026 and has held it in 2 quarters since. 46 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Quantum Financial Partners held 12,300 shares of Amneal Pharmaceuticals worth $248K as of Q3 2026.
  • Quantum Financial Partners bought 2,000 Amneal Pharmaceuticals shares in Q3 2026, an estimated $36K.
  • Amneal Pharmaceuticals made up 0.13% of Quantum Financial Partners's portfolio in Q3 2026, its #133 holding.
  • Quantum Financial Partners first reported a position in Amneal Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 46 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Quantum Financial Partners's 13F filing for Q3 2026, filed 19 Oct 2026.